|
|
奎硫平联合牛黄宁宫片治疗精神分裂症比较分析药学 |
| [生化制药论文]
【关键词】 精神分裂症；奎硫平；牛黄宁宫片
【摘要】 目的 探讨奎硫平联合牛黄宁宫片 治疗 精神分裂症的疗效及安全性。 方法 将113例精神分裂症随机分为 研究 组56例和对照组57例，研究组给予奎硫平联合牛黄宁宫片治疗，对照组单用奎硫平治疗，两组奎硫平平均治疗剂量502.47±75.53mg・d-1，疗程12w。采用简明精神病症状量表、阳性与阴性症状评定量表、总体评定量表和副反应量表于治疗前及治疗第12w末评定临床疗效与不良反应。 结果 12w末研究组痊愈率41.7%，显效率80.4%；对照组痊愈率31.6%，显效率56.1%，两组差异极显著（P＜0.01）。研究组起效较对照组快，不良反应差异不显著。 结论 牛黄宁宫片可增强奎硫平对精神分裂症的总体疗效，安全性高，依从性好。
【关键词】 精神分裂症；奎硫平；牛黄宁宫片
Comparative analyses of quitiapine combined with Niuhuang Ningong tablet in schizophrenia
【Abstract】 Objective To explore the curative effects and safety of quitiapine combined with Niuhuang Ningong tablet in schizophrenia. Methods 113 schizophrenics were randomly divided into research group( took quitiapine combined with Niuhuang Ningong tablet, n=56) and control group(did quitiapine, n=57) for 12 weeks, the mean dosage of quitiapine was 502.47±75.53mg/d for both the 2 groups. Clinical effectiveness and side effects were assessed with The Brief Psychiatric Rating Scale(BPRS), Positive And Negative Symptom Scale(PANSS), Global Assessment Scale(GAS) and Treatment Emergent Symptom Scale(TESS) before treatment and at the end of 12th week of treatment. Results At the end of 12th week, cure and effectual rates were respectively 41.7……
<<<<<全文未完，本文约1609个中文字，未计算英文字母、数字>>>>>
|
|
| |
| 投稿人：7uy |
|
最后编辑：fibg |
生化制药论文 | 生化制药论文 |
|
